申请人:BEECHAM GROUP PLC
公开号:EP0227431A1
公开(公告)日:1987-07-01
A compound of formula (I):
or a salt, ester, amide or solvate thereof, in which,
R. represents hydrogen, substituted or unsubstituted alkyl or an acyl group;
Rb and Rc are independently hydrogen or a substituted or unsubstituted aryl group or a group -ORa; or Rb and Rc together with the carbon atoms to which they are attached form a substituted or unsubstituted carbocyclic group;
Rd and Re are independently hydrogen, substituted or unsubstituted aryl or a group -ORa; or Rd and Re together with the carbon atoms to which they are attached form a substituted or unsubstituted carbocyclic group;
A' represents an alkylene or an alkenylene group;
A2 represents hydrogen, substituted or unsubstituted alkyl or an aralkyl group substituted or unsubstituted in the aryl moiety;
and Het represents a substituted or unsubstituted heterocyclic group; a process for preparing such a compound, a pharmaceutical composition containing such a compound and the use of such compounds and compositions in medicine.
式(I)化合物:
或其盐、酯、酰胺或溶液,其中
R. 代表氢、取代或未取代的烷基或酰基;
Rb 和 Rc 独立地是氢、取代或未取代的芳基或基团 -ORa;或 Rb 和 Rc 与它们所连接的碳原子一起形成取代或未取代的碳环基团;
Rd和Re独立地为氢、取代或未取代的芳基或基团-ORa;或Rd和Re与其所连接的碳原子一起形成取代或未取代的碳环基团;
A' 代表亚烷基或烯基;
A2 代表氢、取代或未取代的烷基或芳基中取代或未取代的芳烷基;
Het 代表取代或未取代的杂环基团;制备这种化合物的工艺、含有这种化合物的药物组合物以及这种化合物和组合物在医药中的用途。